Effects of pyrophosphate on desmal and endochondral mineralization and TNAP activity in organoid culture.
During endochondral and desmal osteogenesis, mineralization of bone and cartilage matrix requires an appropriate solubility product of calcium and phosphate, collagen as a nucleator and deactivation of inhibitors, in order to prevent heterotopic calcification. In the 1960s, Fleisch and coworkers detected pyrophosphate (PPi) as an inhibitor of hydroxyapatite crystal growth, which should be removed by cleavage to tissue non-specific alkaline phosphatase (TNAP) activity. This theory had been established by basic experiments performed with collagen gels and demineralized matrices. In order to investigate the effect of PPi on matrix mineralization in bone and cartilage, calcium content and TNAP activity were measured in organoid cultures of mouse calvarial osteoblasts and limb bud cartilage after treatment with PPi and/or levamisole. In organoid cultures, bone and cartilage develop in a clear histotypical manner. PPi did not induce mineralization. Beta-glycerophosphate (beta-GP) and inorganic phosphate (Pi) induced mineralization which could be significantly reduced by PPi. Levamisole, an inhibitor of TNAP, also reduced mineralization; the combination with PPi was additive. TNAP activity was increased after treatment with PPi and levamisole in both osteoblast and cartilage cultures. Mineralization induced by beta-GP and Pi decreased TNAP activity in the osteoblast but not in cartilage organoid culture. In this culture system, PPi reduced mineralization as predicted by Fleisch's theory. Indications of cleavage of PPi were indirectly found because inhibition of hydrolysis of PPi by levamisole further reduced mineralization, probably due to the higher amounts of PPi available for binding to hydroxyapatite.
Zimmermann
Bernd
B
Zentrum für Anatomie, Charité-Universitätsmedizin Berlin, Campus Mitte, Philippstr. 12, 10115 Berlin, Germany. bernd.zimmermann@charite.de
D000469:Alkaline Phosphatase / Q000037:antagonists & inhibitors; D000818:Animals; D002113:Calcification, Physiologic / Q000187:drug effects* / Q000502:physiology; D002356:Cartilage / Q000187:drug effects / Q000196:embryology / Q000201:enzymology / Q000502:physiology; D011756:Diphosphates / Q000494:pharmacology*; D017886:Durapatite / Q000378:metabolism; D051379:Mice; D008815:Mice, Inbred Strains; D009924:Organ Culture Techniques; D010012:Osteogenesis / Q000187:drug effects* / Q000502:physiology; D012886:Skull / Q000187:drug effects / Q000196:embryology / Q000201:enzymology / Q000502:physiology*
D011756:Diphosphates; D017886:Durapatite; D000469:Alkaline Phosphatase